Catalyst Wire Dossier Catalyst Wire Dossier

Angiocal®

· Pieris Pharmaceuticals GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Angiocal®, covering 2011-10-19 to 2011-10-19. Get the full timeline:

Most recent: Clinical Trial Update: Study of Angiocal® in Patients With Solid Tumors, Investigating Safety, Tolerability, Blood Concentration of Study Drug [Phase 1]

See pricing